Both in Pharmaceuticals
Fulcrum Therapeutics vs Rocket Pharmaceuticals
Over the past year FULC returned −62.7% and RCKT returned −35.9%; their daily moves had a correlation of 0.21.
FULC −62.7% RCKT −35.9%Growth of $1, one year, split-adjusted
| Metric | FULC | RCKT |
|---|---|---|
| Price | $3.73 | $2.55 |
| Market cap | $284.9M | $279.4M |
| Today | +0.81% | +3.88% |
| 1 month | +0.8% | −1.7% |
| 6 months | −47.8% | −26.9% |
| Year to date | −67.0% | −27.5% |
| 1 year | −61.3% | −35.4% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $318.8M | $262.5M |
| Dividend yield | — | — |
| Volatility (60d) | 16.7% | 65.8% |
| Short % of float | 10.6% | 19.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).